#SITC24 Science Preview: Join Stephanie Goff, MD, FACS, National Cancer Institute (NCI), Marco Ruella, MD, University of Pennsylvania and Chrystal Paulos, PhD, Winship Cancer Institute of Emory University. This session delves into the critical role of lymphodepletion as a preparatory step in adoptive T-cell therapies. The speakers will explore the foundations, current practices, and future directions of lymphodepletion strategies to optimize the efficacy of T-cell administration in cancer treatment. View session details: https://lnkd.in/gBW5Cjj7
Society for Immunotherapy of Cancer (SITC)’s Post
More Relevant Posts
-
Early detection is key!
“Cervical cancer is the most preventable cancer, so it is recommended that you attend your cervical screening.” - Dr Dan Cottingham – Cancer Research UK GP Lead. Take a step to #PreventCervicalCancer and book your cervical screening appointment. Find out more information at bit.ly/3RFVk2g.
-
-
"Apologies for the delay, but I'm thrilled to share my certification of participation in the webinar '𝐬𝐢𝐑𝐍𝐀 - 𝐀 𝐧𝐞𝐰 𝐞𝐫𝐚 𝐢𝐧 𝐜𝐚𝐧𝐜𝐞𝐫 𝐜𝐡𝐞𝐦𝐨𝐩𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧' organized by SPSR on the occasion of World Cancer Day, February 4th 🎗️. From this webinar, I learned a lot about how 𝐬𝐢𝐑𝐍𝐀 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 can help prevent cancer. It was fascinating to understand how it works and how it could be used in targeted therapy, latest advancement in cancer research. I feel inspired to be part of cancer research now!" #cancerresearch #sirna #medicaladvancements #healthcareinnovation #learningandgrowing
-
-
Our latest blog explores how new proteogenomics analysis methods and resources like the National Cancer Institute (NCI)’s Clinical Proteomic Tumor Analysis Consortium (#CPTAC) are transforming our understanding of cancer and hastening the promises of #precisionmedicine. Access the full blog on our website: https://lnkd.in/epktXGU7
-
Today is World Cancer Research Day — a reminder of the critical role research plays in transforming lives. At Breast Cancer Canada, we are dedicated to driving progress, working to improve patient outcomes and save lives. Every advancement we make is made possible by science and the support from donors like you. Together, we are moving closer to a future where breast cancer is managed with the least invasive and most effective personalized treatments. Join the progress at: breastcancerprogress.ca #breastcancerresearch
-
-
R&D technical expert | Focus on technical innovation and team management in pharmaceutical R&D, assisting in the development of products from concept to clinical practice
This #BloodCancerAwarenessMonth and #WorldLymphomaAwarenessDay, we’re honoring the progress made in blood cancer research while recognizing there’s still more to be done. Using our deep understanding of cancer biology and cutting-edge technology, we’re facing some of the hardest-to-treat blood cancers head-on, aiming to provide more options to patients in need. #WLAD2024 Learn more about our mission to transform cancer care: https://bit.ly/3T6jFjm
-
Exciting news from ASCO 2024! The latest five-year follow-up results reveal a significant breakthrough in ALK-positive advanced lung cancer, showing prolonged progression-free survival. This milestone is a testament to the advancements in cancer research and treatment. Stay tuned for more updates! #ASCO2024 #LungCancerResearch #MedicalBreakthroughs
-
-
Exciting new commentary by our Conquering KRAS in Pancreatic Cancer TeamLab members, Dr. Anirban Maitra from MD Anderson Cancer Center and Dr. Andrew J. Aguirre from Dana-Farber Cancer Institute is now published in Cancer Research, an American Association for Cancer Research journal. The commentary highlights that advancements in KRAS inhibition for pancreatic cancer are driven by strong collaborations! “The current 'revolution' in KRAS inhibition was made possible by partnerships between oncologists and pathologists, cancer biologists and chemists, and academia and biotech—a spirit of collaboration motivated by the importance of the problem at hand." Read more here: https://lnkd.in/epwWYw-6 #RadicalCollaboration #CancerResearch
-
-
As we reflect on the evolution of HER2, we are reminded of the critical role that research and innovation play in advancing cancer care. Explore five key HER2 milestones in breast cancer research. #CancerResearch #HER2 #BreastCancerAwarenessMonth
-
Introducing cancer care strategy to bend the cancer curve for large employers | emerging benefits champion | breast cancer advocate
Another reminder about next week's webinar. This is a 🔥 subject right now!! #cancer #cancercare #cancertesting #preventativehealth #employeehealth #testing #benefits
Between new imaging techniques, liquid biopsies, and novel methods of sample collection, the landscape of cancer diagnostics is rapidly evolving and expanding. Register to join our upcoming webinar with Dr. William Dahut, Chief Scientific Officer at the American Cancer Society, and Alicia Zhou, PhD, Chief Scientific Officer at Color, on May 28th at 11AM PT/2PM ET for a discussion on “Demystifying and Navigating Current Innovations in Cancer Care.” Register here —> https://lnkd.in/gJizXwJy
Live Webinar | Demystifying & Navigating Current Innovations in Cancer Care
learn.color.com
-
Today is World Cancer Research Day On this important day, we honor the groundbreaking research that is driving new treatments and bringing hope to millions affected by cancer. At NoeticInsight, we recognize the critical role of data-driven insights in advancing cancer research and treatment strategies. Together, we can accelerate progress and move closer to a cure. #WorldCancerResearchDay #CancerResearch
-
